Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection

Journal of NeuroVirology

Volumn 2, Issue 5, 1996, Pages 299-306

  Gessain, Antoine ^a  

^a Institut Pasteur   (France)

Author keywords

Chronic myelopathy; HTLV I; Neurotropism; TSP HAM

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; IMMUNOGLOBULIN G; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

CEREBROSPINAL FLUID; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; THORACIC SPINAL CORD;

DNA VIRUSES; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0029846448     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289609146894     Document Type: Review

References (81)

1. Bangham CR, Daenke S, Phillips RE, Cruickshank JK, Bell JI (1988). Enzymatic amplification of exogenous and endogenous retrovirus sequences from DNA of patients with tropical spastic paraparesis. EMBO J 7: 4179-4184.
2. Bazarbachi A, Huang M, Gessain A, Saal A, Peries J, de Thé H, Galibert F (1995). Human T-cell leukemia virus type I in post-transfusional spastic paraparesis: complete proviral sequence from uncultured blood cells. Int J Cancer 63: 494-499.
3. Beilke MA, In DR, Gravell M, Hamilton RS, Mora CA, Leon-Monzon M, Rodgers-Johnson PEB, Gadjusek DC, Gibbs CJ Jr, Zaninovic V (1991). In situ hybridization detection of HTLV-I RNA in peripheral blood mononuclear cells of TSP/HAM patients and their spouses. J Med Virol 33: 64-71.
4. Boeri E, Gessain A, Garin B, Kazadi K, de Thé G, Franchini G (1993). Qualitative changes in the HTLV-I env gene sequence in the spastic versus nonspastic tropical Paraparesis are not correlated with Disease Specificity. AIDS Res Hum Retroviruses 9: 1-5.
5. Cavrois M, Gessain A, Wain-Hobson S, Wattel E (1996). Proliferation of HTLV-I infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene (in press).
6. Cho I, Sugimoto M, Mita S, Tokunaga M, Imamura F, Ando M (1995). In vivo proviral burden and viral RNA expression in T cell subsets of patients with Human T Lymphotropic Virus Type 1-associated myelopathy/tropical spastic paraparesis. Am J Trop Med Hyg 53(4): 412-418.
7. Daenke S, Nightingale S, Cruickshank JK, Bangham RM (1990). Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol 64: 1278-1282.
8. Daenke S, Kermode AG, Hall SE, Taylor G, Weber J, Nightingale S, Bangham CRM (1995). High cytotoxic effector frequencies occur in healthy HTLV-I carriers and patients with tropical spastic paraparesis. J AIDS & HR 10: 243.
9. Elovaara J, Koenig S, Brewah A, Jacobson S (1993). High HTLV-I specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-I associated neurological disease. J Exp Med 177: 1567-1573.
10. Evangelista A, Maroushek S, Minnigan H, Larson A, Retzel E, Haase A, Gonzales-Dunia D, McFarlin D, Mingioli E, Jacobson S, Osame M, Sonoda S (1990). Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. Microbiol Pathogenesis 8: 259-278.
11. Furukawa Y, Fujisawa J, Osame M, Toita M, Sonoda S, Kubota R, Ijichi S, Yoshida M (1992). Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected cells in HTLV-1 associated myelopathy (HAM/TSP). Blood 80: 1012-1016.
12. Furukawa Y, Osame M, Kubota R, Tara M, Yoshida M (1995). Human T-Cell Leukemia Virus Type-1 (HTLV-1) Tax Is Expressed at the Same Level in Infected Cells of HTLV-1-Associated Myelopathy or Tropical Spastic Paraparesis Patients as in Asymptomatic Carriers but at a Lower Level in Adult T-Cell Leukemia Cells. Blood 85: 1865-1870.
13. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de Thé G (1985). Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 2: 407-410.
14. Gessain A, Gout O (1992). Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I). Annals of Internal Medicine 117: 933-946.
15. Gessain A, Boeri E, Yanahigara R, Gallo RC, Franchini G (1993). Complete nucleotide sequence of a highly divergent HTLV-I variant from Melanesia. Genetic and phylogenetic relationship to HTLV-I strains from other geographical regions. J Virol 67: 1015-1023.
16. Gessain A, Gallo RC, Franchini G (1992). The low degree of HTLV-I genetic drift in vivo as a mean to follow viral transmission and movement of ancient human population. J Virol 66: 2288-2295.
17. Gessain A, de Thé G (1996). Geographical and molecular epidemiology of primate T lymphotropic oncoretroviruses: HTLV-I, HTLV-II, STLV-I, STLV-PP and PTLV-L. Advances in Viral Research (in press).
18. Gessain A, Mahieux R, de Thé G (1996) Genetic variability and molecular epidemiology of Human and Simian T Cell Leukemia/Lymphoma Virus Type I. J AIDS & HR (in press).
19. Gessain A, Caudie C, Gout O, Vernant JC, Maurs L, Giordano C, Malone G, Tournier-Lasserve E, Essex M, de Thé G (1988). Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. J Infec Dis 157: 1226-1234.
20. Gessain A, Saal F, Gout O, Daniel MT, Flandrin G, de Thé G, Peries G, Sigaux F (1990a). High human T-cell lymphotropic virus type 1 proviral DNA load with polyclonal integration in periphal blood mononuclear cells of French West Indian, Guianese and African patients with tropical spastic paraparesis. Blood 75: 428-433.
21. Gessain A, Saal F, Giron ML, Lasneret J, Lagaye S, Gout O, de Thé G, Sigaux F, Peries G (1990b). Cell surface phenotype and human T lymphotropic virus type I antigen expression in 12 T cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guianese and African patients with spastic paraparesis. J Gen Virol 71: 333-341.
22. Gessain A, Louie A, Gout O, Gallo RC, Franchini G (1991). Human T-cell leukemia-lymphoma virus-type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I associated myelopathy. J Virol 65: 1628-1633.
23. Gonzalez-Dunia D, Grimber G, Briand P, Brahic M, Ozden S (1992). Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-I provirus isolated from a case of Tropical spastic paraparesis. Virology 187: 705-710.
24. Gonzalez-Dunia D, Komurian-Pradel F, Chirinian-Syan S, de Thé G, Brahic M, Ozden S (1993). Comparative Analysis of HTLV-I Promoter Activities Reveals No Disease-Linked Pattern of Expression. AIDS Research and Human Retroviruses 9: 337-341.
25. Grimaldi LM, Roos RP, Devare SG, Casey JM, Maruo Y, Hamada T et al (1988). HTLV-I associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody. Ann Neurol 24: 727-731.
26. Hara H, Morita M, Iwaki T, Itoyama Y, Kitamoto T, Akizuki S-I, Goto I, Waranabe T (1994). Detection of Human T Lymphotropic Virus Type I (HTLV-I) Proviral DNA and Analysis of T Cell Receptor Vβ CDR3 Sequences in Spinal Cord Lesions of HTLV-I-associated Myelopathy/Tropical Spastic Paraparesis. J Exp Med 180: 831-839.
27. Höllsberg P, Hafler DP (1995). What is the Pathogenesis of Human T-Cell Lymphotropic Virus Type I-associated Myelopathy/Tropical Spastic Paraparesis? Annals of Neurology 37: 143-145.
28. Höllsberg P, Hafler DP (1993). Pathogenesis of diseases induced by Human Lymphotropic Virus Type I infection. The New England Journal of Medicine 328: 1173-1182.
29. Imamura J, Tsujimoto A, Ohta Y, Hirose S, Shimotohno K, Miwa M, Miyoshi I (1988). DNA blotting analysis of human retroviruses in cerebro-spinal fluid of spastic paraparesis patients: the viruses are identical to human T-cell leukemic virus type-1 (HTLV-I). Int J Cancer 42: 222-224.
30. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990). Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (London) 348: 245-248.
31. Jacobson S (1996). Cellular Immune Responses to HTLV-I: Immunopathogenic Role In HTLV-I Associated Neurologic Disease. J AIDS & HR. (in press).
32. Jacobson S, McFarlin DE, Robinson S, Voskuhl R, Martin R, Brewah A, Newell AJ, Koenig S (1992). HTLV-1-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-1 associated neurological disease. Ann Neurol 32: 651-657.
33. Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G (1991). Predominant recognition of HTLV-I pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I infected cells. Int Immunol 3: 761-767.
34. Kashio N, Izumo S, Ijichi S, Hashimoto K, Umehara F, Higuchi F, Osame M (1994). Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear cells infiltrating spinal cord lesions from HAM/TSP patients. Brain Pathol 4: 498.
35. Kinoshita T, Tsujimoto A, Shimotohno K (1991). Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia. Int J Cancer 47: 491-495.
36. Kira J, Koyanagi Y, Yamada T, Itoyama Y, Goto I, Yamamoto N, Sasaki H, Sakaki Y (1991). Increased HTLV-I proviral DNA in HTLV-I associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 29: 194-201.
37. Kira J, Koyanagi Y, Yamada T, Itoyama Y (1994). Sequence heterogeneity of HTLV-1 proviral DNA in the central nervous system of patients with HTLV-1-associated myelopathy. Ann Neurol 36: 149-156.
38. Koenig S, Woods R, Brewah AH, Newell A, Jones G, Boone E (1993). Characterization of major histocompatibility complex-(MHC) class I restricted cytotoxic T cell (CTL) responses to Tax in HTLV-I infected patients with neurological disease. J Immunol 156: 3874-3883.
39. Komourian F, Pelloquin F, de Thé G (1991). In vivo genomic variability of human T cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 65: 3770-3778.
40. Komourian-Pradel F, Pelloquin F, Sonoda S, de Thé G (1992). Geographical subtypes demonstrated by RFLP following PCR in the LTR region of HTLV-I. AIDS Res Human Retroviruses 8: 429-434.
41. Kubota R, Fujiyoshi T, Izumo S, Yashiki S, Maruuyama I, Osame M, Sonoda S (1993). Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I associated myelopathy. J Neuroimmunol 42: 147-154.
42. Kubota R, Umehara F, Izumo S, Ijichi S, Matsumoto K, Yashiki S, Fujiyoshi T, Sonoda S, Osame M (1994). HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I associated myelopathy. J Neuroimmunol 53: 23-29.
43. Kuroda Y, Matsui M, Kikuchi M, Kurohara K, Endo C, Yukitake M, Matsuda Y, Tokunaga O, Komine-Sakaki A, Kawaguchi R (1994). In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I associated myelopathy. Neurology 44: 2295-2299.
44. Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, Sato E, Raine CS, Osame M, Jacobson S (1995). Detection of Human T-Lymphotropic Virus Type I (HTLV-I) Tax RNA in the Central Nervous System of HTLV-I-associated Myelopathy/Tropical Spastic Paraparesis Patients by In Situ Hybridization. Annals of Neurology 37: 167-175.
45. Lenz J, Gelander D, Crowther RL, Patarca R, Perkins DW, Haseltine WA (1984). Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature 308: 467-470.
46. Levin MC, Fox RJ, Lehky T, Walter M, Fox CH, Flerlage N, Bamford R, Jacobson S (1996). PCR-In Situ Hybridization Detection of Human T-Cell Lymphotropic Virus Type I (HTLV-I) tax Proviral DNA in Peripheral Blood Lymphocytes of Patients with HTLV-I Associated Neurologic Disease. Journal of Virology 70: 924-933.
47. Levin MC, Lehky T, Flerlage N, Katz D, Jacobson S (1995). PCR/in situ hybridization (PCR/ISH) and in situ hybridization (ISH) analysis of HTLV-I tax in the Central nervous system (CNS) of patients with HAM/ TSP. J AIDS and HR 10: 227.
48. Li Y, Golemis E, Hartley JW, Hopkins N (1987). Disease specificity of non defective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J Virol 61: 693-700.
49. Link H, Cruz M, Gessain A, Gout O, de Thé G, KamHansen S (1989). Chronic progressive myelopathy associated with HTLV-I: oligoclonal IgG and antiHTLV-I IgG antibodies in cerebrospinal in cerebrospinal fluid and serum. Neurology 39: 1566-1572.
50. Mahieux R, Gessain A, Truffert A, Vitrac D, Hubert A, Dandelot J, Montchamp-Moreau C, Cnudde F, de Thé G (1994). Seroepidemiology, viral isolation and molecular characterization of Human T cell leukemia/lymphoma virus type I from the Reunion island, Indian Ocean. AIDS Res Hum Retroviruses 10: 745-752.
51. Mahieux R, de Thé G, Gessain A (1995). The tax Mutation at Nucleotide 7959 of Human T-Cell Leukemia Virus Type 1 (HTLV-1) is not associated with Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy but is linked to the Cosmopolitan Molecular Genotype. J Virol 69: 5925-5927.
52. Major ME, Nightingale S, Desselberger U (1993). Complete sequence conservation of the human T cell leukemia virus type 1 tax gene within a family cluster showing different pathologies. J Gen Virol 74: 2531-2537.
53. Moritoyo T, Moritoyo H, Sato E, Osame M, Haase AT (1995). In situ detection of Human T-Lymphotropic Virus Type I in HTLV-I associated Myelopathy/ Tropical spastic paraparesis. J AIDS and HR 10: 227.
54. Muller S, Boire G, Ossondo M, Ricchiuti V, Smadja D, Vernant JC, Ozden S (1995). IgG Autoantibody Response in HTLV-I Infected Patients. Clinical Immunology and Immunopathology 77: 282-290.
55. Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M (1995). HTLV-I associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. Journal of Neuro Virology 1: 50-61.
56. Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, Nightingale S and Bangham CRM (1994). The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol 68: 6778-6781.
57. Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, Nightingale S and Bangham RM. (1995). Naturally Occurring Variants of Human T-Cell Leukemia Virus Type I Tax Protein Impair Its Recognition by Cytoxic T Lymphocytes and the Transactivation Function of Tax. Journal of Virology 69: 2649-2653.
58. Osame M, Ijichi S, Nakagawa M, Umehara F, Higuchi I, Arimura K, Izumo S (1996). HAM/TSP: Recent Perspectives in Japan. J AIDS & HR (in press).
59. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A (1986). HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032.
60. Paine E, Garcia J, Philpott TC, Shaw G, Ratner L (1991). Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African Patients. Virology 182: 111-123.
61. Parker CE, Daenke S, Nightingale S, Bangham CR (1992). Activated, HTLV-I specific cytotoxic T lymphocytes are found in healthy seropositives as well as patients with tropical spastic paraparesis. Virology 188: 628-636.
62. Parker EP, Nightingale S, Taylor GP, Weber J, Bangham CRM (1994). Circulating anti-Tax cytotoxic T-lymphocytes from human T-cell leukemia virus type I infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J Virol 68: 2860-2868.
63. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419.
64. Rassart E, Nelbach L, Jolicoeur P (1986). Cas-Br-E murine leukemia virus: Sequencing of the palalytogenic region of its genome and derivation of specific probes to study its origin and the structure of its recombinant genomes in leukemic isolates. J Virol 60: 910-919.
65. Ratner L, Philpott T, Trowbrige DB (1991). Nucleotide sequence analysis of isolates of human T-lymphotropic virus type I of diverse geographical origins. AIDS Res Hum Retroviruses 7: 923-941.
66. Renjifo B, Borrero I, Essex M (1995). Tax mutation associated with tropical spastic paraparesis/Human T-Cell leukemia virus type I-associated myelopathy. J Virol 69: 2611-2616.
67. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG (1990). In vivo cellular tropism of human T-cell leukemia virus type I. J Virol 64: 5682-5687.
68. Roman GC, Osame M (1988). Identity of HTLV-I associated tropical spastic paraparesis and HTLV-I associated myelopathy. Lancet 1: 651.
69. Schulz TF, Calabro ML, Hoad JG, Carrington CVF, Matutes E, Catovsky D, Weiss R (1991). HTLV-I envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope. Virology 184: 483-491.
70. Saito M, Furukawa Y, Kubota R, Usuku K, Sonoda S, Izumo S, Osame M, Yoshida M (1995). Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions. J NeuroVirology 1: 286-294.
71. Shirabe S, Nakamura T, Tsujihata M, Nagataki S, Seiki M, Yoshida M (1990). Retrovirus from Human T-Cell Leukemia Virus Type I Associated Myelopathy Is the same strain as a Prototype Human T-Cell Leukemia Virus Type I. Arch Neural 47: 1258-1260.
72. Szurek PF, Yuen PH, Jerzy R, Wong PKY (1988). Identification of point mutations in the envelope gene of Moloney murine leukemia virus TB temperature-sensitive paralytogenic mutant tsl: molecular determinants for neurovirulence. Virology 62: 357-360.
73. Takatsuki K, Uchiyama T, Sagawa K, Yodol J. Adult T-cell leukemia in Japan. In: Seno F, Takaku F, Irino S, ed. Topics in hematology. Amsterdam: Excerpta Medica, 1977: 73-77.
74. Tangy F, Vernant J-C, Coscoy L, Ossondo M, Bellance R, Zaninovic V, Cartier L, Brahic M, Ozden S (1995). A Search for Human T-Cell Leukemia Virus Type I in the Lesions of Patients with Tropical Spastic Paraparesis and Polymyositis. Annals of Neurology 38: 454-460.
75. Tendler CL, Greenberg SJ, Blattner WA, Manns A, Murphy E, Fleisher T et al (1990). Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci USA 87: 5218-5222.
76. Tsujimoto A, Teruuchi T, Imamura J, Shimothono K, Miyoshi I, Masanao M (1988). Nucleotide sequence analysis of a provirus derived from HTLV-I associated myelopathy (HAM). Molecular Biology Medicine 50: 481-492.
77. Ureta Vidai A, Gessain A, Yoshida M, Mahieux R, Nishioka K, Tekaia F, Rosen L, de Thé G (1994). Phylogenetic classification of human T cell leukaemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes. J Gen Virol 75: 3655-3666.
78. Wattel E, Cavrois M, Gessain E, Wain Hobson S (1996). Clonal expansion of infected cells - a way of life for HTLV-I. (in press). J AIDS and HR.
79. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S (1995). Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 69: 2863-2868.
80. Xu X, Kang SH, Heidenreich O, Brown DA, Nerenberg MI (1995). HTLV-I associated myelopathy/tropical spastic paraparesis isolates bear mutations in the HTLV-I LTR R region which prevents binding of CREB and ATF-2. J Acquir Immune Defic Syndr 10: 217.
81. Yoshida M, Osame M, Kawai H, Toita M, Kuwasaki N, Nishida Y, Hiraki Y, Takahashi K, Nomura K, Sonoda S, Eiraku N, Ijichi S, Usuku K (1989). Increased replication of HTLV-I in HTLV-1 associated myelopathy. Ann Neurol 36: 331-335.